Anti-platelet drugs, pharmacogenomics and stent thrombosis: What’s new?

Stent thrombosis is a catastrophic complication of percutaneous coronary intervention (PCI) and is associated with a mortality of 25 to 40%. The perception that stent thrombosis is very low in all patients has resulted in a lack of adherence to professional guidelines. New data to identify patients...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: John Benjamin
Formato: article
Lenguaje:EN
Publicado: South African Heart Association 2017
Materias:
Acceso en línea:https://doaj.org/article/30784cb229da45439b3270debb1493bc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!